Over the last 7 days, the Biotech industry has dropped 2.7%, driven by Swedish Orphan Biovitrum declining 3.5%. On the other hand Diamyd Medical is actually up 25%. Over the past 12 months, the industry was up 3.5%. Earnings are forecast to grow by 40% annually.
Has the Swedish Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 11 Jun 2024 | kr196.5b | kr30.6b | -kr5,436,121,775.58 | 38.6x | -36.2x | 6.4x |
Thu, 09 May 2024 | kr186.6b | kr31.0b | -kr5,260,034,088.15 | 51x | -35.5x | 6x |
Sat, 06 Apr 2024 | kr181.4b | kr29.8b | -kr5,279,211,965.11 | 61.5x | -34.4x | 6.1x |
Mon, 04 Mar 2024 | kr179.3b | kr29.8b | -kr5,621,314,313.81 | 51.9x | -31.9x | 6x |
Wed, 31 Jan 2024 | kr327.4b | kr28.7b | -kr1,193,160,809.00 | 60.4x | -274.4x | 11.4x |
Fri, 29 Dec 2023 | kr184.5b | kr28.7b | -kr1,196,011,337.00 | 61.4x | -154.2x | 6.4x |
Sun, 26 Nov 2023 | kr172.5b | kr28.7b | -kr1,155,963,055.00 | 54.2x | -149.3x | 6x |
Tue, 24 Oct 2023 | kr151.2b | kr27.4b | -kr1,985,474,971.00 | 48.5x | -76.1x | 5.5x |
Thu, 21 Sep 2023 | kr164.1b | kr27.4b | -kr2,020,934,417.00 | 51.6x | -81.2x | 6x |
Sat, 19 Aug 2023 | kr152.1b | kr27.6b | -kr1,582,721,433.00 | 53.5x | -96.1x | 5.5x |
Mon, 17 Jul 2023 | kr153.9b | kr26.5b | -kr1,385,021,170.00 | 46.2x | -111.1x | 5.8x |
Wed, 14 Jun 2023 | kr172.2b | kr26.4b | -kr1,256,068,844.00 | 45.9x | -137.1x | 6.5x |
Fri, 12 May 2023 | kr173.9b | kr26.4b | -kr1,361,605,258.00 | 46.1x | -127.7x | 6.6x |
Sun, 09 Apr 2023 | kr171.3b | kr25.4b | -kr2,037,029,771.00 | 38.4x | -84.1x | 6.7x |
Tue, 07 Mar 2023 | kr171.6b | kr25.4b | -kr2,037,396,572.00 | 39.3x | -84.2x | 6.8x |
Thu, 02 Feb 2023 | kr173.6b | kr23.8b | -kr1,873,268,547.00 | 43x | -92.7x | 7.3x |
Sat, 31 Dec 2022 | kr157.8b | kr23.8b | -kr1,842,867,788.00 | 31.5x | -85.6x | 6.6x |
Mon, 28 Nov 2022 | kr162.0b | kr23.8b | -kr1,779,527,645.00 | 31.1x | -91x | 6.8x |
Wed, 26 Oct 2022 | kr149.3b | kr23.3b | -kr3,157,161,955.00 | 32.9x | -47.3x | 6.4x |
Fri, 23 Sep 2022 | kr136.4b | kr22.9b | -kr3,318,799,767.00 | 32.9x | -41.1x | 6x |
Sun, 21 Aug 2022 | kr171.4b | kr22.6b | -kr3,537,561,488.00 | 35.5x | -48.5x | 7.6x |
Tue, 19 Jul 2022 | kr164.4b | kr21.9b | -kr3,481,780,919.00 | 43x | -47.2x | 7.5x |
Thu, 16 Jun 2022 | kr149.6b | kr21.4b | -kr3,528,111,737.00 | 39.2x | -42.4x | 7x |
Sat, 14 May 2022 | kr146.6b | kr21.4b | -kr3,333,951,596.00 | 45.3x | -44x | 6.8x |
Mon, 11 Apr 2022 | kr176.5b | kr19.7b | -kr3,199,792,054.00 | 51.1x | -55.1x | 9x |
Wed, 09 Mar 2022 | kr145.5b | kr19.6b | -kr3,014,129,042.00 | 46.7x | -48.3x | 7.4x |
Fri, 04 Feb 2022 | kr171.5b | kr19.1b | -kr2,253,351,866.00 | 51.8x | -76.1x | 9x |
Sun, 02 Jan 2022 | kr200.6b | kr19.1b | -kr2,003,719,849.00 | 53.3x | -100.1x | 10.5x |
Tue, 30 Nov 2021 | kr201.1b | kr19.0b | -kr1,980,520,932.00 | 53x | -101.5x | 10.6x |
Thu, 28 Oct 2021 | kr200.3b | kr18.9b | -kr1,187,343,383.00 | 54.4x | -168.7x | 10.6x |
Sat, 25 Sep 2021 | kr212.4b | kr18.1b | -kr1,339,284,004.00 | 51.8x | -158.6x | 11.7x |
Mon, 23 Aug 2021 | kr193.7b | kr18.1b | -kr1,175,418,285.95 | 54.5x | -164.8x | 10.7x |
Sat, 10 Jul 2021 | kr170.4b | kr18.1b | -kr1,169,741,285.95 | 58.6x | -145.7x | 9.4x |
-145.7x
Which industries have driven the changes within the Swedish Healthcare industry?
SE Market | -0.72% | |
Healthcare | -1.81% | |
Biotech | -2.70% | |
Biotech | -2.70% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
DMYD B Diamyd Medical | kr14.38 | 25.5% +kr291.2m | 68.8% | PS5085.2x | |
EGTX Egetis Therapeutics | kr9.18 | 7.5% +kr187.2m | 59.4% | PS42.7x | |
BONEX Bonesupport Holding | kr248.40 | 0.9% +kr144.6m | 101.5% | PE61.2x | |
SANION Saniona | kr3.26 | 29.9% +kr83.4m | -65.2% | PS17.5x | |
CRNO B Cereno Scientific | kr4.42 | 3.6% +kr43.3m | 771.0% | PS22.4x |